Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06622005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Autologous Natural Killer Cells in Multiple Myeloma
ClinicalTrials.gov study NCT04558853. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate CART-BCMA in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05346198. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multiple Myeloma Who Are Not Eligible for Transplant
ClinicalTrials.gov study NCT06932562. IPD Sharing: UNDECIDED. Countries: 14. Publications: 0.
Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00017069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05008536. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Multiple Myeloma in Korea
ClinicalTrials.gov study NCT06698887. IPD Sharing: NO. Countries: 1. Publications: 0.
Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment
ClinicalTrials.gov study NCT00802568. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04505813. IPD Sharing: NO. Countries: 1. Publications: 0.
Tandem Transplantation in Multiple Myeloma (MM) Patients With <12 Months of Prior Treatment
ClinicalTrials.gov study NCT00670631. IPD Sharing: Not stated. Countries: 0. Publications: 0.
XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease
ClinicalTrials.gov study NCT01582295. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00002907. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07284758. IPD Sharing: NO. Countries: 1. Publications: 0.
To Compare Conservative Management Vs. Balloon Kyphoplasty in the Treatment of VCFs in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02732925. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CS1-targeted CAR-T Cells Therapy for Relapsed Multiple Myeloma After BCMA CAR-T Cells Therapy
ClinicalTrials.gov study NCT04541368. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT02394210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma
ClinicalTrials.gov study NCT05363800. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatinine Clearance
ClinicalTrials.gov study NCT02849444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
ClinicalTrials.gov study NCT03650491. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects
ClinicalTrials.gov study NCT05646758. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.